A meta-analysis on the efficacy of oral theophylline in patients with stable COPD

References

• AlexanderMRDullWLKasikJE1980Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled studyJAMA2442286907001056
   PubMed Web of Science ®Google Scholar
• AndersonGPeelETPardoeT1982Sustained-release theophylline in chronic bronchitisBr J Dis Chest7626156751366
   PubMedGoogle Scholar
• BarnesPJAdcockIMItoK2005Histone acetylation and deacetylation: importance in inflammatory lung diseasesEur Respir J255526315738302
   PubMed Web of Science ®Google Scholar
• BarnesPJ2003Theophylline: new perspectives for an old drugAm J Respir Crit Care Med1678131812623857
   PubMed Web of Science ®Google Scholar
• BelliaVForesiABiancoS2002Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial)Respir Med96881912418585
   PubMed Web of Science ®Google Scholar
• BerryRBDesaMMBranumJP1991Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary diseaseAm Rev Respir Dis143245501899325
   PubMed Web of Science ®Google Scholar
• BroseghiniCTestiRPoleseG2005A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary diseasePulm Pharmacol Ther18103815649852
   PubMed Web of Science ®Google Scholar
• ChrystynHMulleyBAPeakeMD1988Dose response relation to oral theophylline in severe chronic obstructive airways diseaseBMJ29766621506103147048
   PubMed Web of Science ®Google Scholar
• DonohueJF2004Therapeutic responses in asthma and COPD. BronchodilatorsChest126SupplS12537
   Google Scholar
• DullingerDKronenbergRNiewoehnerDE1986Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstructionChest8917133510820
   PubMed Web of Science ®Google Scholar
• FinkGKayeCSulkesJ1994Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary diseaseThorax4933248202902
   PubMed Web of Science ®Google Scholar
• GuyattGHTownsendMPugsleySO1987Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of lifeAm Rev Respir Dis1351069743579005
   PubMed Web of Science ®Google Scholar
• LimSJatakanonAGordonD2000Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practiceThorax558374110992535
   PubMed Web of Science ®Google Scholar
• MahlerDAMatthayRASnyderPE1985Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway diseaseAm Rev Respir Dis1312253966709
   PubMed Web of Science ®Google Scholar
• MarvinPMBakerBJDuttAK1983Physiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary diseaseChest8468496641302
   PubMed Web of Science ®Google Scholar
• NewmanDTamirJSpeedyL1994Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary diseaseIsr J Med Sci30811167982769
   PubMedGoogle Scholar
• NishimuraKKoyamaHIkedaA1993Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?Chest104179848325065
   PubMed Web of Science ®Google Scholar
• NishimuraKKoyamaHIkedaA1995The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPDChest107718237874943
   PubMed Web of Science ®Google Scholar
• OliverBTomitaKKellerA2001Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophagesAllergy5610879011703224
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASMaP2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summaryRespir Care4679882511463370
   PubMedGoogle Scholar
• RamFSJardinJRAtallahA2005Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysisRespir Med991354415715180
   PubMed Web of Science ®Google Scholar
• RossiAKristufekPLevineBE2002Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPDChest12110586911948033
   PubMed Web of Science ®Google Scholar
• SchmidtRAltschulerS1979The usefulness of theophylline in nonasthmatic airway obstructionAngiology307449389103
   PubMed Web of Science ®Google Scholar
• Schultze-WerninghausGMeier-SydowJ1982The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922Clin Allergy12211157042115
   PubMedGoogle Scholar
• ShivaramUCashMEMateoF1997Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPDRespir Med91327349282234
   PubMed Web of Science ®Google Scholar
• ThomasPPugsleyJAStewartJH1992Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary diseaseChest10116051729064
   PubMed Web of Science ®Google Scholar
• TsukinoMNishimuraKIkedaA1998Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary diseaseThorax53269739741369
   PubMed Web of Science ®Google Scholar
• ZuWallackRLMahlerDAReillyD2001Salmeterol plus theophylline combination therapy in the treatment of COPDChest11916617011399688
   PubMed Web of Science ®Google Scholar